{"pmid":32352401,"title":"Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States.","text":["Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States.","Background Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV2), is an ongoing pandemic that has already affected millions of patients worldwide, and is associated with significant morbidity and mortality burden. Although the clinical and laboratory characteristics of this illness have been reported in patients from China and Europe, data are scant in the United States. Methods We extracted data regarding all patients hospitalized at our hospital with COVID-19 infection between March 1 and April 4, 2020. Presenting signs and symptoms, laboratory and imaging findings, treatment, and complications were recorded from electronic medical records (EMRs). The primary composite endpoint was admission to intensive care unit (ICU), shock, or death. Results We had a total of 43 patients tested for COVID-19 at the emergency room (ER) or during hospitalization, 16 (37%) of whom were admitted with COVID-19 infection. The mean age was 65.5 years and 75% were males. The most common presenting symptoms were fever (94%), cough (88%), and dyspnea (81%). A loss of smell and taste sensations were reported by three (19%) patients. Low oxygen saturation was present in 38% of patients, whilst 31% were hypotensive on admission. Hyponatremia (50%), elevated C-reactive protein (CRP; 100%), and lactate dehydrogenase (LDH; 80%) were common. Acute renal failure, myocardial injury, and elevation in aminotransferases occurred in 69%, 19%, and 38% patients, respectively. The primary composite endpoint occurred in 50% of patients. A total of three patients died; all were aged 70 years or older. Conclusions Laboratory abnormalities and acute renal failure were common in hospitalized patients with SARS-CoV2 infection in our center. Admission to ICU and mechanical ventilation were common.","Diagnosis (Berl)","Aggarwal, Saurabh","Garcia-Telles, Nelson","Aggarwal, Gaurav","Lavie, Carl","Lippi, Giuseppe","Henry, Brandon Michael","32352401"],"abstract":["Background Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV2), is an ongoing pandemic that has already affected millions of patients worldwide, and is associated with significant morbidity and mortality burden. Although the clinical and laboratory characteristics of this illness have been reported in patients from China and Europe, data are scant in the United States. Methods We extracted data regarding all patients hospitalized at our hospital with COVID-19 infection between March 1 and April 4, 2020. Presenting signs and symptoms, laboratory and imaging findings, treatment, and complications were recorded from electronic medical records (EMRs). The primary composite endpoint was admission to intensive care unit (ICU), shock, or death. Results We had a total of 43 patients tested for COVID-19 at the emergency room (ER) or during hospitalization, 16 (37%) of whom were admitted with COVID-19 infection. The mean age was 65.5 years and 75% were males. The most common presenting symptoms were fever (94%), cough (88%), and dyspnea (81%). A loss of smell and taste sensations were reported by three (19%) patients. Low oxygen saturation was present in 38% of patients, whilst 31% were hypotensive on admission. Hyponatremia (50%), elevated C-reactive protein (CRP; 100%), and lactate dehydrogenase (LDH; 80%) were common. Acute renal failure, myocardial injury, and elevation in aminotransferases occurred in 69%, 19%, and 38% patients, respectively. The primary composite endpoint occurred in 50% of patients. A total of three patients died; all were aged 70 years or older. Conclusions Laboratory abnormalities and acute renal failure were common in hospitalized patients with SARS-CoV2 infection in our center. Admission to ICU and mechanical ventilation were common."],"journal":"Diagnosis (Berl)","authors":["Aggarwal, Saurabh","Garcia-Telles, Nelson","Aggarwal, Gaurav","Lavie, Carl","Lippi, Giuseppe","Henry, Brandon Michael"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352401","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1515/dx-2020-0046","keywords":["sars-cov2","coronavirus","demographics","outcomes"],"locations":["China","United States","United States"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138495649841152,"score":9.490897,"similar":[{"pmid":32417380,"title":"Coronavirus Disease 2019 in Heart Transplant Recipients in Southeastern Michigan - Case Series.","text":["Coronavirus Disease 2019 in Heart Transplant Recipients in Southeastern Michigan - Case Series.","BACKGROUND: Since coronavirus disease 2019 (Covid-19) was first identified in Wuhan, China in December 2019, the number of cases has risen exponentially. Clinical characteristics and outcomes among patients with orthotopic heart transplant (OHT) with Covid-19 remain poorly described. METHODS: We performed a retrospective case series of patients with OHT with Covid-19 admitted to one of two hospitals in Southeastern Michigan between March 21 and April 22, 2020. Clinical data were obtained through review of the electronic medical record. Final date of follow-up was May 7, 2020. Demographic, clinical, laboratory, radiological, treatment, and mortality data were collected and analyzed. RESULTS: We identified 13 patients with OHT admitted with Covid-19. The mean (+/-SD) age of patients was 61+/-12 years, 100% were black males, and symptoms began 6+/-4 days before admission. The most common symptoms included subjective fever (92%), shortness of breath (85%), and cough (77%). Six (46%) required admission to the intensive care unit. Two patients (15%) died during hospitalization. CONCLUSIONS: Black men may be at increased risk for Covid-19 among patients with OHT. Presenting signs and symptoms in this cohort are similar to those in the general population. Elevated inflammatory markers on presentation appear to be associated with more severe illness.","J Card Fail","Ketcham, Scott W","Adie, Sarah K","Malliett, Ashley","Abdul-Aziz, Ahmad A","Bitar, Abbas","Grafton, Gillian","Konerman, Matthew C","32417380"],"abstract":["BACKGROUND: Since coronavirus disease 2019 (Covid-19) was first identified in Wuhan, China in December 2019, the number of cases has risen exponentially. Clinical characteristics and outcomes among patients with orthotopic heart transplant (OHT) with Covid-19 remain poorly described. METHODS: We performed a retrospective case series of patients with OHT with Covid-19 admitted to one of two hospitals in Southeastern Michigan between March 21 and April 22, 2020. Clinical data were obtained through review of the electronic medical record. Final date of follow-up was May 7, 2020. Demographic, clinical, laboratory, radiological, treatment, and mortality data were collected and analyzed. RESULTS: We identified 13 patients with OHT admitted with Covid-19. The mean (+/-SD) age of patients was 61+/-12 years, 100% were black males, and symptoms began 6+/-4 days before admission. The most common symptoms included subjective fever (92%), shortness of breath (85%), and cough (77%). Six (46%) required admission to the intensive care unit. Two patients (15%) died during hospitalization. CONCLUSIONS: Black men may be at increased risk for Covid-19 among patients with OHT. Presenting signs and symptoms in this cohort are similar to those in the general population. Elevated inflammatory markers on presentation appear to be associated with more severe illness."],"journal":"J Card Fail","authors":["Ketcham, Scott W","Adie, Sarah K","Malliett, Ashley","Abdul-Aziz, Ahmad A","Bitar, Abbas","Grafton, Gillian","Konerman, Matthew C"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32417380","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.cardfail.2020.05.008","keywords":["advanced heart failure","covid","heart transplant","immunosuppression"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667058206777540608,"score":162.68248},{"pmid":32444880,"title":"Clinical Features and Outcomes of 105 Hospitalized patients with COVID-19 in Seattle, Washington.","text":["Clinical Features and Outcomes of 105 Hospitalized patients with COVID-19 in Seattle, Washington.","BACKGROUND: Washington State served as the initial epicenter of the SARS-CoV-2 pandemic in the United States. An understanding of the risk factors and clinical outcomes of hospitalized patients with COVID-19 may provide guidance for management. METHODS: All laboratory-confirmed COVID-19 cases in adults admitted to an academic medical center in Seattle, WA between March 2 and March 26, 2020 were included. We evaluated individuals with and without severe disease, defined as admission to the intensive care unit or death. RESULTS: One-hundred-five COVID-19 patients were hospitalized. Thirty-five percent were admitted from a senior home or skilled nursing facility. The median age was 69 years and half were women.Three or more comorbidities were present in 55% of patients, with hypertension (59%), obesity (47%), cardiovascular disease (38%) and diabetes (33%) being the most prevalent. Most (63%) had symptoms for 5 days or longer prior to admission. Only 39% had fever in the first 24 hours, whereas 41% had hypoxia at admission. Seventy-three percent of patients had lymphopenia. Of 50 samples available for additional testing, no viral coinfections were identified. Severe disease occurred in 49%. Eighteen percent of patients were placed on mechanical ventilation and the overall mortality rate was 33%. CONCLUSIONS: During the early days of the COVID-19 epidemic in Washington State, the disease had its greatest impact on elderly patients with medical comorbidities. We observed high rates of severe disease and mortality in our hospitalized patients.","Clin Infect Dis","Buckner, Frederick S","McCulloch, Denise J","Atluri, Vidya","Blain, Michela","McGuffin, Sarah A","Nalla, Arun K","Huang, Meei-Li","Greninger, Alex L","Jerome, Keith R","Cohen, Seth A","Neme, Santiago","Green, Margaret L","Chu, Helen Y","Kim, H Nina","32444880"],"abstract":["BACKGROUND: Washington State served as the initial epicenter of the SARS-CoV-2 pandemic in the United States. An understanding of the risk factors and clinical outcomes of hospitalized patients with COVID-19 may provide guidance for management. METHODS: All laboratory-confirmed COVID-19 cases in adults admitted to an academic medical center in Seattle, WA between March 2 and March 26, 2020 were included. We evaluated individuals with and without severe disease, defined as admission to the intensive care unit or death. RESULTS: One-hundred-five COVID-19 patients were hospitalized. Thirty-five percent were admitted from a senior home or skilled nursing facility. The median age was 69 years and half were women.Three or more comorbidities were present in 55% of patients, with hypertension (59%), obesity (47%), cardiovascular disease (38%) and diabetes (33%) being the most prevalent. Most (63%) had symptoms for 5 days or longer prior to admission. Only 39% had fever in the first 24 hours, whereas 41% had hypoxia at admission. Seventy-three percent of patients had lymphopenia. Of 50 samples available for additional testing, no viral coinfections were identified. Severe disease occurred in 49%. Eighteen percent of patients were placed on mechanical ventilation and the overall mortality rate was 33%. CONCLUSIONS: During the early days of the COVID-19 epidemic in Washington State, the disease had its greatest impact on elderly patients with medical comorbidities. We observed high rates of severe disease and mortality in our hospitalized patients."],"journal":"Clin Infect Dis","authors":["Buckner, Frederick S","McCulloch, Denise J","Atluri, Vidya","Blain, Michela","McGuffin, Sarah A","Nalla, Arun K","Huang, Meei-Li","Greninger, Alex L","Jerome, Keith R","Cohen, Seth A","Neme, Santiago","Green, Margaret L","Chu, Helen Y","Kim, H Nina"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32444880","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1093/cid/ciaa632","keywords":["covid-19","sars-cov-2","comorbidities","hospitalized","outcomes"],"locations":["United States","Seattle","Washington State","Seattle","Washington"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667600475798634497,"score":159.3794},{"pmid":32109013,"pmcid":"PMC7092819","title":"Clinical Characteristics of Coronavirus Disease 2019 in China.","text":["Clinical Characteristics of Coronavirus Disease 2019 in China.","BACKGROUND: Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of the affected patients. METHODS: We extracted data regarding 1099 patients with laboratory-confirmed Covid-19 from 552 hospitals in 30 provinces, autonomous regions, and municipalities in mainland China through January 29, 2020. The primary composite end point was admission to an intensive care unit (ICU), the use of mechanical ventilation, or death. RESULTS: The median age of the patients was 47 years; 41.9% of the patients were female. The primary composite end point occurred in 67 patients (6.1%), including 5.0% who were admitted to the ICU, 2.3% who underwent invasive mechanical ventilation, and 1.4% who died. Only 1.9% of the patients had a history of direct contact with wildlife. Among nonresidents of Wuhan, 72.3% had contact with residents of Wuhan, including 31.3% who had visited the city. The most common symptoms were fever (43.8% on admission and 88.7% during hospitalization) and cough (67.8%). Diarrhea was uncommon (3.8%). The median incubation period was 4 days (interquartile range, 2 to 7). On admission, ground-glass opacity was the most common radiologic finding on chest computed tomography (CT) (56.4%). No radiographic or CT abnormality was found in 157 of 877 patients (17.9%) with nonsevere disease and in 5 of 173 patients (2.9%) with severe disease. Lymphocytopenia was present in 83.2% of the patients on admission. CONCLUSIONS: During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness. Patients often presented without fever, and many did not have abnormal radiologic findings. (Funded by the National Health Commission of China and others.).","N Engl J Med","Guan, Wei-Jie","Ni, Zheng-Yi","Hu, Yu","Liang, Wen-Hua","Ou, Chun-Quan","He, Jian-Xing","Liu, Lei","Shan, Hong","Lei, Chun-Liang","Hui, David S C","Du, Bin","Li, Lan-Juan","Zeng, Guang","Yuen, Kwok-Yung","Chen, Ru-Chong","Tang, Chun-Li","Wang, Tao","Chen, Ping-Yan","Xiang, Jie","Li, Shi-Yue","Wang, Jin-Lin","Liang, Zi-Jing","Peng, Yi-Xiang","Wei, Li","Liu, Yong","Hu, Ya-Hua","Peng, Peng","Wang, Jian-Ming","Liu, Ji-Yang","Chen, Zhong","Li, Gang","Zheng, Zhi-Jian","Qiu, Shao-Qin","Luo, Jie","Ye, Chang-Jiang","Zhu, Shao-Yong","Zhong, Nan-Shan","32109013"],"abstract":["BACKGROUND: Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of the affected patients. METHODS: We extracted data regarding 1099 patients with laboratory-confirmed Covid-19 from 552 hospitals in 30 provinces, autonomous regions, and municipalities in mainland China through January 29, 2020. The primary composite end point was admission to an intensive care unit (ICU), the use of mechanical ventilation, or death. RESULTS: The median age of the patients was 47 years; 41.9% of the patients were female. The primary composite end point occurred in 67 patients (6.1%), including 5.0% who were admitted to the ICU, 2.3% who underwent invasive mechanical ventilation, and 1.4% who died. Only 1.9% of the patients had a history of direct contact with wildlife. Among nonresidents of Wuhan, 72.3% had contact with residents of Wuhan, including 31.3% who had visited the city. The most common symptoms were fever (43.8% on admission and 88.7% during hospitalization) and cough (67.8%). Diarrhea was uncommon (3.8%). The median incubation period was 4 days (interquartile range, 2 to 7). On admission, ground-glass opacity was the most common radiologic finding on chest computed tomography (CT) (56.4%). No radiographic or CT abnormality was found in 157 of 877 patients (17.9%) with nonsevere disease and in 5 of 173 patients (2.9%) with severe disease. Lymphocytopenia was present in 83.2% of the patients on admission. CONCLUSIONS: During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness. Patients often presented without fever, and many did not have abnormal radiologic findings. (Funded by the National Health Commission of China and others.)."],"journal":"N Engl J Med","authors":["Guan, Wei-Jie","Ni, Zheng-Yi","Hu, Yu","Liang, Wen-Hua","Ou, Chun-Quan","He, Jian-Xing","Liu, Lei","Shan, Hong","Lei, Chun-Liang","Hui, David S C","Du, Bin","Li, Lan-Juan","Zeng, Guang","Yuen, Kwok-Yung","Chen, Ru-Chong","Tang, Chun-Li","Wang, Tao","Chen, Ping-Yan","Xiang, Jie","Li, Shi-Yue","Wang, Jin-Lin","Liang, Zi-Jing","Peng, Yi-Xiang","Wei, Li","Liu, Yong","Hu, Ya-Hua","Peng, Peng","Wang, Jian-Ming","Liu, Ji-Yang","Chen, Zhong","Li, Gang","Zheng, Zhi-Jian","Qiu, Shao-Qin","Luo, Jie","Ye, Chang-Jiang","Zhu, Shao-Yong","Zhong, Nan-Shan"],"date":"2020-02-29T11:00:00Z","year":2020,"_id":"32109013","source":"PubMed","week":"20209|Feb 24 - Mar 01","doi":"10.1056/NEJMoa2002032","link_comment_in":"32220206","locations":["Wuhan","China","China","Wuhan","Wuhan","Lymphocytopenia","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1666138490769768448,"score":158.00769},{"pmid":32373237,"pmcid":"PMC7196305","title":"Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients.","text":["Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients.","Rationale: Chest computed tomography (CT) has been used for the coronavirus disease 2019 (COVID-19) monitoring. However, the imaging risk factors for poor clinical outcomes remain unclear. In this study, we aimed to assess the imaging characteristics and risk factors associated with adverse composite endpoints in patients with COVID-19 pneumonia. Methods: This retrospective cohort study enrolled patients with laboratory-confirmed COVID-19 from 24 designated hospitals in Jiangsu province, China, between 10 January and 18 February 2020. Clinical and initial CT findings at admission were extracted from medical records. Patients aged < 18 years or without available clinical or CT records were excluded. The composite endpoints were admission to ICU, acute respiratory failure occurrence, or shock during hospitalization. The volume, density, and location of lesions, including ground-glass opacity (GGO) and consolidation, were quantitatively analyzed in each patient. Multivariable logistic regression models were used to identify the risk factors among age and CT parameters associated with the composite endpoints. Results: In this study, 625 laboratory-confirmed COVID-19 patients were enrolled; among them, 179 patients without an initial CT at admission and 25 patients aged < 18 years old were excluded and 421 patients were included in analysis. The median age was 48.0 years and the male proportion was 53% (224/421). During the follow-up period, 64 (15%) patients had a composite endpoint. There was an association of older age (odds ratio [OR], 1.04; 95% confidence interval [CI]: 1.01-1.06; P = 0.003), larger consolidation lesions in the upper lung (Right: OR, 1.13; 95%CI: 1.03-1.25, P =0.01; Left: OR,1.15; 95%CI: 1.01-1.32; P = 0.04) with increased odds of adverse endpoints. Conclusion: There was an association of older age and larger consolidation in upper lungs on admission with higher odds of poor outcomes in patients with COVID-19.","Theranostics","Yu, Qian","Wang, Yuancheng","Huang, Shan","Liu, Songqiao","Zhou, Zhen","Zhang, Shijun","Zhao, Zhen","Yu, Yizhou","Yang, Yi","Ju, Shenghong","32373237"],"abstract":["Rationale: Chest computed tomography (CT) has been used for the coronavirus disease 2019 (COVID-19) monitoring. However, the imaging risk factors for poor clinical outcomes remain unclear. In this study, we aimed to assess the imaging characteristics and risk factors associated with adverse composite endpoints in patients with COVID-19 pneumonia. Methods: This retrospective cohort study enrolled patients with laboratory-confirmed COVID-19 from 24 designated hospitals in Jiangsu province, China, between 10 January and 18 February 2020. Clinical and initial CT findings at admission were extracted from medical records. Patients aged < 18 years or without available clinical or CT records were excluded. The composite endpoints were admission to ICU, acute respiratory failure occurrence, or shock during hospitalization. The volume, density, and location of lesions, including ground-glass opacity (GGO) and consolidation, were quantitatively analyzed in each patient. Multivariable logistic regression models were used to identify the risk factors among age and CT parameters associated with the composite endpoints. Results: In this study, 625 laboratory-confirmed COVID-19 patients were enrolled; among them, 179 patients without an initial CT at admission and 25 patients aged < 18 years old were excluded and 421 patients were included in analysis. The median age was 48.0 years and the male proportion was 53% (224/421). During the follow-up period, 64 (15%) patients had a composite endpoint. There was an association of older age (odds ratio [OR], 1.04; 95% confidence interval [CI]: 1.01-1.06; P = 0.003), larger consolidation lesions in the upper lung (Right: OR, 1.13; 95%CI: 1.03-1.25, P =0.01; Left: OR,1.15; 95%CI: 1.01-1.32; P = 0.04) with increased odds of adverse endpoints. Conclusion: There was an association of older age and larger consolidation in upper lungs on admission with higher odds of poor outcomes in patients with COVID-19."],"journal":"Theranostics","authors":["Yu, Qian","Wang, Yuancheng","Huang, Shan","Liu, Songqiao","Zhou, Zhen","Zhang, Shijun","Zhao, Zhen","Yu, Yizhou","Yang, Yi","Ju, Shenghong"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32373237","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.7150/thno.46465","keywords":["covid-19 pneumonia","ct scan","outcome","risk factor"],"locations":["Jiangsu","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138496434176000,"score":157.73383},{"pmid":32461326,"title":"Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series.","text":["Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series.","BACKGROUND: Pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with high intensive care unit (ICU) mortality. We aimed to describe the clinical characteristics and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19) in a Canadian setting. METHODS: We conducted a retrospective case series of critically ill patients with laboratory-confirmed SARS-CoV-2 infection consecutively admitted to 1 of 6 ICUs in Metro Vancouver, British Columbia, Canada, between Feb. 21 and Apr. 14, 2020. Demographic, management and outcome data were collected by review of patient charts and electronic medical records. RESULTS: Between Feb. 21 and Apr. 14, 2020, 117 patients were admitted to the ICU with a confirmed diagnosis of COVID-19. The median age was 69 (interquartile range [IQR] 60-75) years, and 38 (32.5%) were female. At least 1 comorbidity was present in 86 (73.5%) patients. Invasive mechanical ventilation was required in 74 (63.2%) patients. The duration of mechanical ventilation was 13.5 (IQR 8-22) days overall and 11 (IQR 6-16) days for patients successfully discharged from the ICU. Tocilizumab was administered to 4 patients and hydroxychloroquine to 1 patient. As of May 5, 2020, a total of 18 (15.4%) patients had died, 12 (10.3%) remained in the ICU, 16 (13.7%) were discharged from the ICU but remained in hospital, and 71 (60.7%) were discharged home. INTERPRETATION: In our setting, mortality in critically ill patients with COVID-19 admitted to the ICU was lower than in previously published studies. These data suggest that the prognosis associated with critical illness due to COVID-19 may not be as poor as previously reported.","CMAJ","Mitra, Anish R","Fergusson, Nicholas A","Lloyd-Smith, Elisa","Wormsbecker, Andrew","Foster, Denise","Karpov, Andrei","Crowe, Sarah","Haljan, Greg","Chittock, Dean R","Kanji, Hussein D","Sekhon, Mypinder S","Griesdale, Donald E G","32461326"],"abstract":["BACKGROUND: Pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with high intensive care unit (ICU) mortality. We aimed to describe the clinical characteristics and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19) in a Canadian setting. METHODS: We conducted a retrospective case series of critically ill patients with laboratory-confirmed SARS-CoV-2 infection consecutively admitted to 1 of 6 ICUs in Metro Vancouver, British Columbia, Canada, between Feb. 21 and Apr. 14, 2020. Demographic, management and outcome data were collected by review of patient charts and electronic medical records. RESULTS: Between Feb. 21 and Apr. 14, 2020, 117 patients were admitted to the ICU with a confirmed diagnosis of COVID-19. The median age was 69 (interquartile range [IQR] 60-75) years, and 38 (32.5%) were female. At least 1 comorbidity was present in 86 (73.5%) patients. Invasive mechanical ventilation was required in 74 (63.2%) patients. The duration of mechanical ventilation was 13.5 (IQR 8-22) days overall and 11 (IQR 6-16) days for patients successfully discharged from the ICU. Tocilizumab was administered to 4 patients and hydroxychloroquine to 1 patient. As of May 5, 2020, a total of 18 (15.4%) patients had died, 12 (10.3%) remained in the ICU, 16 (13.7%) were discharged from the ICU but remained in hospital, and 71 (60.7%) were discharged home. INTERPRETATION: In our setting, mortality in critically ill patients with COVID-19 admitted to the ICU was lower than in previously published studies. These data suggest that the prognosis associated with critical illness due to COVID-19 may not be as poor as previously reported."],"journal":"CMAJ","authors":["Mitra, Anish R","Fergusson, Nicholas A","Lloyd-Smith, Elisa","Wormsbecker, Andrew","Foster, Denise","Karpov, Andrei","Crowe, Sarah","Haljan, Greg","Chittock, Dean R","Kanji, Hussein D","Sekhon, Mypinder S","Griesdale, Donald E G"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32461326","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1503/cmaj.200794","locations":["Canadian","British Columbia","Canada","Vancouver","Canada"],"countries":["Canada"],"countries_codes":["CAN|Canada"],"e_drugs":["tocilizumab","Hydroxychloroquine"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1668079521253818368,"score":154.29713}]}